Catalyst Wire Dossier Catalyst Wire Dossier

INI-822

· Inipharm Australia Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INI-822, covering 2025-02-05 to 2025-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH [Phase 1]

See pricing